Two members of Taiwan's main opposition Kuomintang (KMT) said Monday they will ask a court to revoke the emergency use authorization (EUA) granted to a locally developed COVID-19 vaccine candidate that has not started Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiex ends at new high as TSMC smashes closing records on AI
06/22/2026 05:13 PM - Culture
Scholar uses rare skill to decode work shining light on Taiwan's past
06/22/2026 04:48 PM - Culture
Taiwan's Tseng Jing-hua wins Best Lead Actor at Global OTT Awards
06/22/2026 04:27 PM - Business
U.S. dollar closes higher on Taipei forex market
06/22/2026 04:18 PM - Business
Confidence in economy improves amid AI boom: Poll
06/22/2026 03:31 PM